Literature DB >> 16525045

Calcium signaling pathways mediating synaptic potentiation triggered by amyotrophic lateral sclerosis IgG in motor nerve terminals.

Mario R Pagani1, Ricardo C Reisin, Osvaldo D Uchitel.   

Abstract

Sporadic amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects particularly motoneurons. Several pieces of evidence suggested the involvement of autoimmune mechanisms mediated by antibodies in ALS. However, the significance of those antibodies in the disease and the underlying mechanisms are unknown. Here we showed that IgG purified from a group of sporadic ALS patients, but not familial ALS patients, specifically interact with the presynaptic membrane of motoneurons through an antigen-antibody interaction and modulated synaptic transmission. Immunoreactivity against nerve terminals showed strong correlation with synaptic modulation ability. In addition, several controls have ruled out the possibility for this synaptic modulation to be mediated through proteases or nonspecific effects. Effective IgG potentiated both spontaneous and asynchronous transmitter release. Application of pharmacological inhibitors suggested that activation of this increased release required a nonconstitutive Ca2+ influx through N-type (Cav2.2) channels and phospholipase C activity and that activation of IP3 and ryanodine receptors were necessary to both activate and sustain the increased release. Consistent with the notion that ALS is heterogeneous disorder, our results reveal that, in approximately 50% of ALS patients, motor nerve terminals constitutes a target for autoimmune response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16525045      PMCID: PMC6675160          DOI: 10.1523/JNEUROSCI.4394-05.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  64 in total

Review 1.  Immunology of the neuromuscular junction and presynaptic nerve terminal.

Authors:  A Vincent
Journal:  Curr Opin Neurol       Date:  1999-10       Impact factor: 5.710

2.  PI-3 kinase and IP3 are both necessary and sufficient to mediate NT3-induced synaptic potentiation.

Authors:  F Yang; X He; L Feng; K Mizuno; X W Liu; J Russell; W C Xiong; B Lu
Journal:  Nat Neurosci       Date:  2001-01       Impact factor: 24.884

3.  Localization of pepstatin's inhibitory action during Fc-mediated antibody internalization: possible implications for antibody-mediated viral transmission.

Authors:  I Athanassakis; E Protopapadakis; S Vassiliadis
Journal:  Cell Immunol       Date:  2000-02-01       Impact factor: 4.868

4.  Resistance of extraocular motoneuron terminals to effects of amyotrophic lateral sclerosis sera.

Authors:  D R Mosier; L Siklós; S H Appel
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

Review 5.  From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS.

Authors:  D W Cleveland; J D Rothstein
Journal:  Nat Rev Neurosci       Date:  2001-11       Impact factor: 34.870

6.  Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis.

Authors:  C Guégan; M Vila; G Rosoklija; A P Hays; S Przedborski
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

7.  Ultrastructural analysis of spinal motoneurones from mice treated with IgG from ALS patients, healthy individuals, or disease controls.

Authors:  A H Pullen; P Humphreys
Journal:  J Neurol Sci       Date:  2000-11-01       Impact factor: 3.181

8.  Intraterminal Ca(2+) and spontaneous transmitter release at the frog neuromuscular junction.

Authors:  J K Angleson; W J Betz
Journal:  J Neurophysiol       Date:  2001-01       Impact factor: 2.714

9.  Functional coupling of Ca(2+) channels to ryanodine receptors at presynaptic terminals. Amplification of exocytosis and plasticity.

Authors:  K Narita; T Akita; J Hachisuka; S Huang; K Ochi; K Kuba
Journal:  J Gen Physiol       Date:  2000-04       Impact factor: 4.086

10.  Amyotrophic lateral sclerosis IgG-treated neuromuscular junctions develop sensitivity to L-type calcium channel blocker.

Authors:  S A Fratantoni; G Weisz; A M Pardal; R C Reisin; O D Uchitel
Journal:  Muscle Nerve       Date:  2000-04       Impact factor: 3.217

View more
  19 in total

1.  Increased asynchronous release and aberrant calcium channel activation in amyloid precursor protein deficient neuromuscular synapses.

Authors:  L Yang; B Wang; C Long; G Wu; H Zheng
Journal:  Neuroscience       Date:  2007-08-28       Impact factor: 3.590

2.  The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis.

Authors:  Yingying Zhang; Aaron Burberry; Jin-Yuan Wang; Jackson Sandoe; Sulagna Ghosh; Namrata D Udeshi; Tanya Svinkina; Daniel A Mordes; Joanie Mok; Maura Charlton; Quan-Zhen Li; Steven A Carr; Kevin Eggan
Journal:  Genes Dev       Date:  2018-06-27       Impact factor: 11.361

3.  Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.

Authors:  Carsten W Lederer; Antonietta Torrisi; Maria Pantelidou; Niovi Santama; Sebastiano Cavallaro
Journal:  BMC Genomics       Date:  2007-01-23       Impact factor: 3.969

4.  Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS.

Authors:  Thomas W Gould; Robert R Buss; Sharon Vinsant; David Prevette; Woong Sun; C Michael Knudson; Carol E Milligan; Ronald W Oppenheim
Journal:  J Neurosci       Date:  2006-08-23       Impact factor: 6.167

5.  Modulation of spontaneous motor unit potentials by a new motor cortical magnetic stimulation method in amyotrophic lateral sclerosis.

Authors:  Santosh A Helekar; Jason Thonhoff; Blessy S John; Lisa Nguyen; David B Rosenfield; Stanley H Appel
Journal:  J Neurol       Date:  2022-06-15       Impact factor: 6.682

6.  L-type Ca2+ Channels at Low External Calcium Differentially Regulate Neurotransmitter Release in Proximal-Distal Compartments of the Frog Neuromuscular Junction.

Authors:  A N Tsentsevitsky; A M Petrov
Journal:  Cell Mol Neurobiol       Date:  2021-10-04       Impact factor: 4.231

Review 7.  Control of intracellular calcium signaling as a neuroprotective strategy.

Authors:  R Scott Duncan; Daryl L Goad; Michael A Grillo; Simon Kaja; Andrew J Payne; Peter Koulen
Journal:  Molecules       Date:  2010-03-03       Impact factor: 4.411

8.  Autoimmunity in amyotrophic lateral sclerosis: past and present.

Authors:  Mario Rafael Pagani; Laura Elisabeth Gonzalez; Osvaldo Daniel Uchitel
Journal:  Neurol Res Int       Date:  2011-08-01

9.  Humoral immune activation in amyotrophic lateral sclerosis patients.

Authors:  Michael Rentzos; Maria Eleftheria Evangelopoulos; Eleni Sereti; Vassiliki Zouvelou; Styliani Marmara; Theodoros Alexakis; Ioannis Evdokimidis
Journal:  Neurol Int       Date:  2013-02-11

Review 10.  Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights.

Authors:  Steve Vucic; Ulf Ziemann; Andrew Eisen; Mark Hallett; Matthew C Kiernan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-12-21       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.